3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Cyclophosphamide
37
Cytarabine
27
Methotrexate
22
Dexamethasone
20
Vincristine
19
fludarabine
15
Mercaptopurine
14
Etoposide
14
Radiotherapy
12
Daunorubicin
12
Asparaginase
12
Doxorubicin
11
Prednisolone
9
Idarubicin
9
Busulfan
8
pegaspargase
7
blinatumomab
7
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Immunotherapy, Adoptive
6
Imatinib Mesylate
6
Dasatinib
6
fludarabine phosphate
5
Prednisone
5
Methylprednisolone
5
Filgrastim
5
Whole-Body Irradiation
4
Thioguanine
4
Rituximab
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Blood Specimen Collection
×
Clear all
NCT02345915
2017-09-05
LEA-JA
Institut Paoli-Calmettes
Phase NA
Unknown
90 enrolled